Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.

Passero FC Jr, Ravi D, McDonald JT, Beheshti A, David KA, Evens AM.

Br J Haematol. 2019 Aug 26. doi: 10.1111/bjh.16160. [Epub ahead of print]

PMID:
31452195
2.

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients.

Samsen A, von der Heyde S, Bokemeyer C, David KA, Flath B, Graap M, Grebenstein B, Heflik L, Hollburg W, Layer P, von Leitner E, Overkamp F, Saeger W, Schneider S, von Seydewitz CU, Stang A, Stein A, Zornig C, Juhl H.

Oncotarget. 2018 Oct 5;9(78):34794-34809. doi: 10.18632/oncotarget.26198. eCollection 2018 Oct 5.

3.

Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?

David KA, Kritharis A, Evens AM.

Lancet Haematol. 2018 May;5(5):e186-e187. doi: 10.1016/S2352-3026(18)30049-8. Epub 2018 Apr 9. No abstract available.

PMID:
29650494
4.

Clinical Studies in Hematologic Microtransplantation.

David KA, Cooper D, Strair R.

Curr Hematol Malig Rep. 2017 Feb;12(1):51-60. doi: 10.1007/s11899-017-0361-6. Review.

PMID:
28229282
5.

Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue.

Unger FT, Lange N, Krüger J, Compton C, Moore H, Agrawal L, Juhl H, David KA.

J Transl Med. 2016 Jan 8;14:6. doi: 10.1186/s12967-015-0752-1.

6.

Metabolomics profiling of pre-and post-anesthesia plasma samples of colorectal patients obtained via Ficoll separation.

Ghini V, Unger FT, Tenori L, Turano P, Juhl H, David KA.

Metabolomics. 2015;11(6):1769-1778. doi: 10.1007/s11306-015-0832-5. Epub 2015 Jul 25.

7.

Identification and Validation of a Potential Marker of Tissue Quality Using Gene Expression Analysis of Human Colorectal Tissue.

Lange N, Unger FT, Schöppler M, Pursche K, Juhl H, David KA.

PLoS One. 2015 Jul 29;10(7):e0133987. doi: 10.1371/journal.pone.0133987. eCollection 2015.

8.

Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue.

David KA, Unger FT, Uhlig P, Juhl H, Moore HM, Compton C, Nashan B, Dörner A, de Weerth A, Zornig C.

Oncotarget. 2014 Nov 30;5(22):11017-28. doi: 10.18632/oncotarget.2669.

9.

Prediction of individual response to anticancer therapy: historical and future perspectives.

Unger FT, Witte I, David KA.

Cell Mol Life Sci. 2015 Feb;72(4):729-57. doi: 10.1007/s00018-014-1772-3. Epub 2014 Nov 12. Review.

10.

Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).

Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM.

J Urol. 2011 May;185(5):1631-6. doi: 10.1016/j.juro.2010.12.049. Epub 2011 Mar 21.

PMID:
21419456
11.

Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.

David KA, Mongan NP, Smith C, Gudas LJ, Nanus DM.

Cancer Biol Ther. 2010 May 1;9(9):678-84. Epub 2010 May 8.

12.

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA, Jovanovic B, Chadburn A, Stiff P, Winter JN, Mehta J, Van Besien K, Gregory S, Gordon LI, Shammo JM, Smith SE, Smith SM.

J Clin Oncol. 2010 Feb 20;28(6):1038-46. doi: 10.1200/JCO.2009.25.4961. Epub 2010 Jan 19.

13.

Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.

David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.

Cancer. 2009 Apr 1;115(7):1435-47. doi: 10.1002/cncr.24147.

14.

Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.

David KA, Mauro L, Evens AM.

Curr Treat Options Oncol. 2007 Oct;8(5):352-74. doi: 10.1007/s11864-007-0046-9. Review.

PMID:
18214690
15.

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.

David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.

J Urol. 2007 Aug;178(2):451-4. Epub 2007 Jun 11.

PMID:
17561135
16.

Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels.

Fentz AK, Spörl M, Spangenberg J, List HJ, Zornig C, Dörner A, Layer P, Juhl H, David KA.

Proteomics Clin Appl. 2007 Jun;1(6):536-44. doi: 10.1002/prca.200600664. Epub 2007 May 14.

PMID:
21136704
17.

Chemotherapy for non-clear-cell renal cell carcinoma.

David KA, Milowsky MI, Nanus DM.

Clin Genitourin Cancer. 2006 Mar;4(4):263-8. Review.

PMID:
16729909
18.

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.

David KA, Milowsky MI, Kostakoglu L, Vallabhajosula S, Goldsmith SJ, Nanus DM, Bander NH.

Clin Genitourin Cancer. 2006 Mar;4(4):249-56. Review.

PMID:
16729907
19.

Detection and quantification of mutations in the plasma of patients with colorectal tumors.

Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA Jr, Goodman SN, David KA, Juhl H, Kinzler KW, Vogelstein B.

Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16368-73. Epub 2005 Oct 28.

20.

Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.

Schlomm T, Luebke AM, Sültmann H, Hellwinkel OJ, Sauer U, Poustka A, David KA, Chun FK, Haese A, Graefen M, Erbersdobler A, Huland H.

Int J Oncol. 2005 Sep;27(3):713-20.

PMID:
16077921
21.

Evaluating risk factors for the development of ifosfamide encephalopathy.

David KA, Picus J.

Am J Clin Oncol. 2005 Jun;28(3):277-80. Review.

PMID:
15923801
22.

Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision.

Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, Spangenberg J, Zornig C, Juhl HH, David KA.

Biotechniques. 2004 Jun;36(6):1030-7.

23.

Key role of mitochondria in cerulenin-mediated apoptosis.

Heiligtag SJ, Bredehorst R, David KA.

Cell Death Differ. 2002 Sep;9(9):1017-25.

24.

Thermoluminescence characteristics of sodium chloride salt-stressed Indian mustard seedlings.

Biswal AK, Dilnawaz F, Ramaswamy NK, David KA, Misra AN.

Luminescence. 2002 May-Jun;17(3):135-40.

PMID:
12164362
25.

Increase in the intensity of thermoluminescence Q-band during leaf ageing is due to a block in the electron transfer from Q( A) to Q( B).

Biswal AK, Dilnawaz F, David KA, Ramaswamy NK, Misra AN.

Luminescence. 2001 Sep-Oct;16(5):309-13.

PMID:
11590702
26.
27.

Covalently cross-linked immune complexes prepared with multivalent cross-linking antigens.

Mannik M, David KA.

J Immunol. 1981 Nov;127(5):1999-2006.

PMID:
7299122
29.
30.

Conformational changes in the nitrogenase complex in vivo by preincubation under acetylene.

Apte SK, David KA, Thomas J.

Biochem Biophys Res Commun. 1978 Aug 14;83(3):1157-63. No abstract available.

PMID:
101215
31.

Stimulation of nitrogenase by acetylene: fresh synthesis or conformational chance?

David KA, Apte SK, Thomas J.

Biochem Biophys Res Commun. 1978 May 15;82(1):39-45. No abstract available.

PMID:
96835
32.

Effects of long-term treatment with acetylene on nitrogen-fixing microorganisms.

David KA, Fay P.

Appl Environ Microbiol. 1977 Dec;34(6):640-6.

33.

Unusual resistance to ultraviolet light in dark phase of blue-green bacterium Anacystis nidulans.

Bhattacharjee SK, David KA.

Nature. 1977 Jan 13;265(5590):183-4. No abstract available.

PMID:
401948
34.

Site of nitrogenase activity in the blue-green alga Anabaena sp. L-31.

Thomas J, David KA.

Nat New Biol. 1972 Aug 16;238(85):219-21. No abstract available.

PMID:
4626450

Supplemental Content

Loading ...
Support Center